← Leaderboards
David A Thorley-Lawson
Tufts University Boston
$13,752,380
Attributed
$13,752,380
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$14,059,619 · 8
By mechanism
R01$12,845,141 · 3
S10$1,214,478 · 5
Top collaborators
No co-investigators on record.
Most similar at Tufts University Boston
Same institution · by research overlap
- Brigitte T. Huber$10,217,193
- Natalie A Sutkowski$698,687
- Michael D. Shapiro$623,160
- Theoharis C Theoharides$6,368,490
- Alexander Poltorak$15,343,099
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoIn VitroCellsInfectionB-LymphocytesBaseMemory B-LymphocyteHerpesviridaeProteinsTonsilFlow CytometryEpstein-Barr Virus InfectionsHuman Herpesvirus 4TumorInfected B CellMemoryPolymerase Chain ReactionLmp1VirusMalignant NeoplasmsLymphomaB LymphocyteSignal TransductionGenes
Grant awards (41)
Host Immunity to EBV Infection in Vitro and in Vivo$412,500
R01 · FY2016 · AI · contact PI
Host Immunity to EBV Infection in Vitro and in Vivo$412,500
R01 · FY2015 · AI · contact PI
Host Immunity to EBV Infection in Vitro and in Vivo$412,500
R01 · FY2014 · AI · contact PI
Epstein Barr Virus Latency$325,660
R01 · FY2014 · CA · contact PI
BD Influx 5 Laser Fluorescence Activated Cell Sorter$600,000
S10 · FY2013 · OD · contact PI
Host Immunity to EBV Infection in Vitro and in Vivo$387,750
R01 · FY2013 · AI · contact PI
Epstein Barr Virus Latency$315,589
R01 · FY2013 · CA · contact PI
Host Immunity to EBV Infection in Vitro and in VIvo$404,291
R01 · FY2012 · AI · contact PI
Epstein Barr Virus Latency$335,732
R01 · FY2012 · CA · contact PI
Host Immunity to EBV Infection in Vitro and in VIvo$404,291
R01 · FY2011 · AI · contact PI
Epstein Barr Virus Latency$335,732
R01 · FY2011 · CA · contact PI
Host Immunity to EBV Infection in Vitro and in VIvo$408,375
R01 · FY2010 · AI · contact PI
Epstein Barr Virus Latency$346,116
R01 · FY2010 · CA · contact PI
Computer Simulation of Epstein Barr Virus Infection$452,643
R01 · FY2009 · AI · contact PI
Host Immunity to EBV Infection in Vitro and in VIvo$411,979
R01 · FY2009 · AI · contact PI
Computer Simulation of Epstein Barr Virus Infection$440,562
R01 · FY2008 · AI · contact PI
Host Immunity to EBV Infection in Vitro and in VIvo$410,729
R01 · FY2008 · AI · contact PI
Epstein Barr Virus Latency$304,330
R01 · FY2008 · CA · contact PI
Computer Simulation of Epstein Barr Virus Infection$434,393
R01 · FY2007 · AI · contact PI
Host Immunity to EBV Infection in Vitro and in Vivo$354,696
R01 · FY2007 · AI · contact PI
Epstein Barr Virus Latency$304,530
R01 · FY2007 · CA · contact PI
Computer Simulation of Epstein Barr Virus Infection$438,244
R01 · FY2006 · AI · contact PI
Host Immunity to EBV Infection in Vitro and in Vivo$364,632
R01 · FY2006 · AI · contact PI
Epstein Barr Virus Latency$313,419
R01 · FY2006 · CA · contact PI
LSRII Four Laser Analytical Flow Cytometer$307,239
S10 · FY2006 · RR · contact PI
FLOW CYTOMETERS FOR ANALYSIS (FACSCALIBUR) AND SORTING: PATHOLOGY, IMMUNOLOGY$227,357
S10 · FY2006 · RR · contact PI
FLOW CYTOMETERS FOR ANALYSIS (FACSCALIBUR) AND SORTING: CANCER$49,158
S10 · FY2006 · RR · contact PI
FLOW CYTOMETERS FOR ANALYSIS (FACSCALIBUR) AND SORTING: AGING, LYME ARTHRITIS$30,724
S10 · FY2006 · RR · contact PI
Computer Simulation of Epstein Barr Virus Infection$461,253
R01 · FY2005 · AI
Host Immunity to EBV Infection in Vitro and in Vivo$372,763
R01 · FY2005 · AI
Epstein Barr Virus Latency$320,963
R01 · FY2005 · CA
Host Immunity to EBV Infection in Vitro and in Vivo$372,142
R01 · FY2004 · AI
Epstein Barr Virus Latency$320,963
R01 · FY2004 · CA
Host Immunity to EBV Infection in Vitro and in Vivo$371,545
R01 · FY2003 · AI
EPSTEIN BARR VIRUS LATENCY$291,424
R01 · FY2003 · CA
HOST IMMUNITY TO EBV INFECTION IN VITRO AND IN VIVO$281,655
R01 · FY2002 · AI
EPSTEIN BARR VIRUS LATENCY$269,342
R01 · FY2002 · CA
HOST IMMUNITY TO EBV INFECTION IN VITRO AND IN VIVO$273,450
R01 · FY2001 · AI
EPSTEIN BARR VIRUS LATENCY$261,496
R01 · FY2001 · CA
HOST IMMUNITY TO EBV INFECTION IN VITRO AND IN VIVO$265,485
R01 · FY2000 · AI
EPSTEIN BARR VIRUS LATENCY$251,467
R01 · FY2000 · CA